Skip to main content
Clinical Trials/NCT06082297
NCT06082297CompletedNot Applicable

Can Blood Flow Enhancing Plantar Flexion Electrically Induced Via Textile Electrodes in a Sock Using 1 Hz Frequency Give Better Comfort and Energy Efficiency as Compared to 36 Hz ?

Karolinska University Hospital1 site in 1 country15 target enrollmentStarted: July 17, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
15
Locations
1
Primary Endpoint
Average duration of blood pulse (ADBP)

Study Overview

Brief Summary

Muscle contractions induced by calf low-intensity neuromuscular electrical stimulation (C-LI-NMES) can increase venous return and may reduce venous thromboembolism. This study aimed to compare the effect of different C-LI-NMES frequencies and plateau times on hemodynamics, discomfort and energy efficiency, when applied via sock-integrated transverse textile electrodes.

Detailed Description

Fifteen healthy participants were stimulated via two 3x3cm transverse textile electrodes integrated in a sock, with ten different combinations of frequency (1Hz or 36Hz) and plateau times (0.5/1.5/3/5/7s), with gradually increasing NMES-intensity until plantar flexion-induction. At this point, popliteal peak venous velocity (PVV), time-averaged mean velocity (TAMV) and ejection volume (EV) were assessed by Doppler-ultrasound, discomfort by a numerical rating scale (NRS, 0-10) and values for current amplitude and energy were calculated based on the NMES-device´s intensity level. Values expressed with median (interquartile range), significance set to p<0.05.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Sequential
Primary Purpose
Basic Science
Masking
None

Masking Description

Participants did not receive information about what parameter-settings that were used for the different tests.

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 18-99 years of age
  • •Voluntary participation

Exclusion Criteria

  • •Pregnancy
  • •Pacemaker
  • •Ongoing thromboprophylaxis
  • •Skin wounds
  • •Vascular abnormalities
  • •Previous vascular system surgery in the lower limbs

Arms & Interventions

Single arm where repeated measures where performed in 15 participants.

Experimental

Each of the 15 participants in the arm was, in addition to the resting state (no intervention), exposed to 10 different interventions repeated after each other to enable repeated measures of the outcomes.

Intervention: Chattanooga Physio, DJO, neuromuscular electrical stimulation (Device)

Outcomes

Primary Outcomes

Average duration of blood pulse (ADBP)

Time Frame: Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention

Average duration of blood pulse will be assesed by Doppler ultrasound in the popliteal vein (seconds)

Time averaged mean velocity (TAMV)

Time Frame: Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention

Time averaged mean velocity will be assesed by Doppler ultrasound in the popliteal vein (centimeters per second)

Ejection volume (EV)

Time Frame: Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention

Ejection volume of blood will be assesed by Doppler ultrasound in the popliteal vein (milliliters)

Peak venous velocity (PVV)

Time Frame: Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention

Peak venous velocity (centimeters per second) will be assesed by Doppler ultrasound of in the popliteal vein

Secondary Outcomes

  • Current amplitude(Day 1 during ankle plantar flexion was induced by the intervention)
  • Numerical rating scale (NRS)(Day 1 during ankle plantar flexion was induced by the intervention)
  • Energy(Day 1 during ankle plantar flexion was induced by the intervention)

Investigators

Sponsor
Karolinska University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Paul Ackermann

Professor,MD,PhD

Karolinska University Hospital

Study Sites (1)

Loading locations...

Similar Trials